Virginia Retirement Systems Et Al Revance Therapeutics, Inc. Transaction History

Virginia Retirement Systems Et Al

  • $10.1 Billion
  • Q3 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 22, 2023
SELL
$24.7 - $37.61 $7,410 - $11,283
-300 Reduced 2.14%
13,700 $346,000
Q1 2023

Jul 11, 2023
BUY
$18.36 - $35.27 $16,524 - $31,743
900 Added 6.87%
14,000 $450,000
Q4 2022

May 17, 2023
BUY
$18.32 - $30.66 $239,992 - $401,646
13,100 New
13,100 $242 Million
Q3 2022

May 16, 2023
SELL
$14.33 - $28.47 $318,126 - $632,034
-22,200 Closed
0 $0
Q1 2022

Apr 21, 2022
BUY
$12.36 - $20.31 $274,392 - $450,882
22,200 New
22,200 $433,000

Others Institutions Holding RVNC

# of Institutions
234
Shares Held
82.8M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email